Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
Apellis Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Apellis Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, five executives at Apellis Pharmaceuticals received on average a compensation package of $2.6M, a 64% increase compared to previous year.
Average pay of disclosed executives at Apellis Pharmaceuticals
Cedric Francois, Chief Executive Officer, received $4.1M in total, which increased by 145% compared to 2017. 77% of Francois' compensation, or $3.1M, was in option awards. Francois also received $382K in bonus, $550K in salary, as well as $15K in other compensation.
Lukas Scheibler, Chief Innovation Officer, received a compensation package of $3.6M. 90% of the compensation package, or $3.3M, was in option awards.
Federico Grossi, Chief Medical Officer, earned $2.8M in 2018.
Pascal Deschatelets, Chief Operating Officer, received $1.9M in 2018, which increases by 116% compared to 2017.
Timothy Sullivan, Chief Financial Officer, earned $860K in 2018, a 63% decrease compared to previous year.
Related executives
Cedric Francois
Apellis Pharmaceuticals
Chief Executive Officer
Timothy Sullivan
Apellis Pharmaceuticals
Chief Financial Officer
Pascal Deschatelets
Apellis Pharmaceuticals
Chief Scientific Officer
Federico Grossi
Apellis Pharmaceuticals
Chief Medical Officer
Lukas Scheibler
Apellis Pharmaceuticals
Chief Innovation Officer
You may also like
Source: SEC filing on April 30, 2019.